Not himself/herself after Bedinvetmab (Librela) in dogs

The FDA has received 484 reports of not himself/herself in dogs after Bedinvetmab. That is 2.5% of all reports for this medicine, compared with 0.3% across reports for all dog medicines, so it is reported unusually often with this medicine.

484Reports

69%Marked serious

13%Recovered

28%Died or euthanised

7 daysTypical onset

How soon it started

Same day

104 24%

1–2 days

76 18%

3–7 days

44 10%

1–4 weeks

87 20%

Over a month

119 28%

How the animals did

Recovered

64 13%

Still unwell when reported

235 49%

Died

40 8.3%

Euthanised

96 20%

Not known

49 10%

Problems reported at the same time

191 39%

176 36%

135 28%

107 22%

83 17%

80 17%

69 14%

66 14%

Age of the animals

Under 1 year

1–3 years

4–7 years

8–11 years

163

12+ years

257

About this medicine

Bedinvetmab reduces osteoarthritis pain in dogs (monthly injection).

Products with this ingredient include Librela. The FDA hides brand names in its public data, so these reports cover every product with the same active ingredients.

Questions owners ask

Can Bedinvetmab cause not himself/herself in dogs?: 484 reports link the two, but a report alone does not prove the medicine was the cause: other illnesses, other medicines or coincidence can be involved. Your vet can judge it for your animal.
How soon after a dose was it reported?: In half of the reports with dates, it started within 7 days of the first dose.
What should I do?: Don't give another dose until you've spoken to your vet, and keep the packaging so you can tell them the product and dose. Your vet can also report it to the FDA (or you can, through the manufacturer or FDA form 1932a).

Not himself/herself with similar medicines

Not himself/herself after Lokivetmab (Cytopoint) 84 reports · 1.3% of its reports

All reported side effects of Bedinvetmab in dogs · Medicines most reported with not himself/herself